Genetic Testing + Education for Flushing

FY
JL
Overseen ByJennifer L Young, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwestern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn whether education plus genetic testing for ALDH2\*2 and ADH1B\*2 is feasible and acceptable and whether it influences modifiable health behaviors in East Asian American adults who experience alcohol flushing when they drink alcohol or have a family history of flushing. The main questions it aims to answer are:

1. Is providing education plus ALDH2\*2/ADH1B\*2 genetic testing feasible and acceptable in a clinical care context?

2. Does receiving genetic testing results plus education lead to changes in modifiable health behaviors compared with education alone? Researchers will compare education plus genetic testing (intervention arm) to education only (control arm) to see if adding genetic testing improves feasibility/acceptability and supports health behavior change.

Participants will:

1. Complete an education module about alcohol flushing and ALDH2/ADH1B

2. Be randomized to either: (A) Receive genetic testing for ALDH2\*2 and ADH1B\*2 with results disclosure, or (B) Receive education only.

3. Complete follow-up measures about feasibility, acceptability, and modifiable health behaviors

Who Is on the Research Team?

JL

Jennifer L Young, PhD

Principal Investigator

Northwestern U

Are You a Good Fit for This Trial?

This trial is for East Asian American adults who experience alcohol flushing or have a family history of it. It's focused on whether adding genetic testing to education about alcohol flushing can change health behaviors.

Inclusion Criteria

Self-identified as East Asian and/or East Asian American
Flush when they drink alcohol or have a family member who flushes when they drink
Able to read and speak English
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Education Module

Participants complete an education module about alcohol flushing and ALDH2/ADH1B

1 week
1 visit (virtual)

Intervention

Participants are randomized to either receive genetic testing with results disclosure or education only

4 weeks
1 visit (in-person or virtual)

Follow-up

Participants complete follow-up measures about feasibility, acceptability, and modifiable health behaviors

4 weeks
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • ALDH2 Genetic Testing

Trial Overview

The study tests if providing ALDH2*2/ADH1B*2 genetic testing along with education is more effective than just education in influencing health behavior changes related to rosacea, Alzheimer's, esophageal cancer, and cardiovascular disease.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Alcohol Flushing Education AND Genetic TestingExperimental Treatment2 Interventions
Group II: Alcohol Flushing Education OnlyActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Northwestern University Feinberg School of Medicine

Collaborator

Trials
42
Recruited
15,500+